Summary of DIA Workshop: Comparability Challenges: Regulatory and Scientific Issues in the Assessment of Biopharmaceuticals

被引：7
|
作者：
Lewis, Richard M. [1 ]
Cosenza, Mary Ellen [1 ]
机构：
[1] Amgen Inc, Regulatory Affairs, Thousand Oaks, CA USA
来源：
DRUG INFORMATION JOURNAL | 2010年 / 44卷 / 04期
关键词：
Comparability; Regulatory; Biological product; Pharmacokinetics; Pharmacodynamics; Biochemical; Analyses; MONOCLONAL-ANTIBODY; GLYCOSYLATION; PHARMACOKINETICS; PANITUMUMAB; RECEPTOR;
D O I：
10.1177/009286151004400413
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
On February 3-4, 2009, a DIA Workshop was held to review and discuss comparability challenges and issues for biotechnology-derived pharmaceuticals. The workshop was held in the Washington, DC, area and was attended by representatives from the FDA and biotech and pharmaceutical industries. The expectation was to develop a consensus on which data are necessary to provide assurance of comparability for manufacturing changes made to biotechnology products during different stages of development or postmarketing. Numerous case studies were reviewed and discussed to build on best practices and recognize successful approaches to comparability.
引用
收藏
页码：485 / 504
页数：20
相关论文
共 25 条
  • [1] Summary of DIA Workshop: Comparability Challenges: Regulatory and Scientific Issues in the Assessment of Biopharmaceuticals
    Richard M. Lewis
    Mary Ellen Cosenza
    Drug information journal : DIJ / Drug Information Association, 2010, 44 (4): : 485 - 504
  • [2] Current Perspective on Comparability Issues Summary of DIA Meeting
    Cosenza, Mary Ellen
    INTERNATIONAL JOURNAL OF TOXICOLOGY, 2010, 29 (01) : 122 - 122
  • [3] IMMUNOHISTOCHEMISTRY PRODUCTS WORKSHOP - FORUM ON THE SCIENTIFIC AND REGULATORY ISSUES
    SWANSON, PE
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1994, 102 (04) : 508 - 514
  • [4] Challenges and Opportunities in Establishing Scientific and Regulatory Standards for Assuring Therapeutic Equivalence of Modified Release Products: Workshop Summary Report
    Mei-Ling Chen
    Vinod P. Shah
    Derek Ganes
    Kamal K. Midha
    James Caro
    Prabu Nambiar
    Mario L. Rocci
    Avinash G. Thombre
    Bertil Abrahamsson
    Dale Conner
    Barbara Davit
    Paul Fackler
    Colm Farrell
    Suneel Gupta
    Russell Katz
    Mehul Mehta
    Sheldon H. Preskorn
    Gerard Sanderink
    Salomon Stavchansky
    Robert Temple
    Yaning Wang
    Helen Winkle
    Lawrence Yu
    The AAPS Journal, 2010, 12 (3) : 371 - 377
  • [5] Challenges and Opportunities in Establishing Scientific and Regulatory Standards for Determining Therapeutic Equivalence of Modified-Release Products: Workshop Summary Report
    Chen, Mei-Ling
    Shah, Vinod P.
    Ganes, Derek
    Midha, Kamal K.
    Cao, James
    Nambiar, Prabu
    Rocci, Mario L., Jr.
    Thombre, Avinash G.
    Abrahamsson, Bertil
    Conner, Dale
    Davit, Barbara
    Fackler, Paul
    Farrell, Colm
    Gupta, Suneel
    Katz, Russell
    Mehta, Mehul
    Preskorn, Sheldon H.
    Sanderink, Gerard
    Stavchansky, Salomon
    Temple, Robert
    Wang, Yaning
    Winklel, Helen
    Yu, Lawrence
    CLINICAL THERAPEUTICS, 2010, 32 (10) : 1704 - 1712
  • [6] Executive summary: Scientific and regulatory challenges of development of probiotics as foods and drugs
    Hoffman, Freddie Ann
    Heimbach, James T.
    Sanders, Mary Ellen
    Hibberd, Patricia L.
    CLINICAL INFECTIOUS DISEASES, 2008, 46 : S53 - S57
  • [7] Challenges and opportunities in establishing scientific and regulatory standards for assuring therapeutic equivalence of modified-release products: Workshop summary report
    Chen, Mei-Ling
    Shah, Vinod P.
    Ganes, Derek
    Midha, Kamal K.
    Caro, James
    Nambiar, Prabu
    Rocci, Mario L., Jr.
    Thombre, Avinash G.
    Abrahamsson, Bertil
    Conner, Dale
    Davit, Barbara
    Fackler, Paul
    Farrell, Colm
    Gupta, Suneel
    Katz, Russell
    Mehta, Mehul
    Preskorn, Sheldon H.
    Sanderink, Gerard
    Stavchansky, Salomon
    Temple, Robert
    Wang, Yaning
    Winkle, Helen
    Yu, Lawrence
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2010, 40 (02) : 148 - 153
  • [8] SUMMARY OF THE WORKSHOP ON ISSUES IN RISK ASSESSMENT - QUANTITATIVE METHODS FOR DEVELOPMENTAL TOXICOLOGY
    MATTISON, DR
    SANDLER, JD
    RISK ANALYSIS, 1994, 14 (04) : 595 - 604
  • [9] The Concept of Resilience in Ecological Risk Assessment: Scientific and Regulatory Issues
    Vighi, Marco
    Rico, Andreu
    INTEGRATED ENVIRONMENTAL ASSESSMENT AND MANAGEMENT, 2018, 14 (05) : 581 - 585
  • [10] Workshop overview: Scientific and regulatory challenges for the reduction, refinement, and replacement of animals in toxicity testing
    Purchase, IFH
    Botham, PA
    Bruner, LH
    Flint, OP
    Frazier, JM
    Stokes, WS
    TOXICOLOGICAL SCIENCES, 1998, 43 (02) : 86 - 101
123